MedCu is proud to be the first company to gain FDA and CE clearances for marketing copper-based wound dressings. Leveraging copper’s potent antibacterial properties, MedCu provides a unique proposition to address acute, postop and chronic wounds. The copper-based wound dressings follow the successful commercialization of copper compounds impregnation into various fabrics and polymers after 15 years of research and are protected by 30 patents worldwide.
| Website | http://www.medcu.com |
| Revenue | $1 million |
| Employees | 11 (8 on RocketReach) |
| Founded | 2017 |
| Industry | Medical Devices, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| Keywords | Wound Care Solutions, Chronic Wound Management, Medical Device Technology, Infection Prevention, Medical Dressings, Surgical Wound Care, Burn Wound Treatment, Healthcare Technology |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Stryker, BD, Boston Scientific, Cardinal Health, Zimmer Biomet, Teleflex, Smiths Medical +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular MedCu Technologies Ltd. employee's phone or email?
The MedCu Technologies Ltd. annual revenue was $1 million in 2026.
Danny Lustiger is the CEO and Founder of MedCu Technologies Ltd..
8 people are employed at MedCu Technologies Ltd..
The NAICS codes for MedCu Technologies Ltd. are [3254, 32541, 325, 32].
The SIC codes for MedCu Technologies Ltd. are [283, 28].